Curaleaf Holdings
Corporate brand
UnclaimedCuraleaf Holdings is a large vertically integrated U.S. cannabis company operating dispensaries, cultivation and processing under consumer brands such as Select and Grassroots.
Last updated October 30, 2026
AI crawler reads
No AI crawler has read this profile yet.
Overview
Curaleaf Holdings is a vertically integrated cannabis company headquartered in New York, formed in 2017 and publicly listed on the Canadian Securities Exchange under the ticker CURA, with its shares also quoted in the United States on the OTCQX market as CURLF. It is one of the largest multi-state operators in the U.S. legal cannabis industry, active across cultivation, processing, wholesale distribution and retail dispensing. The company operates a national network of Curaleaf-branded dispensaries and sells both its own cultivated flower and processed products and a portfolio of consumer brands. Its brand family includes Select, a well-known cannabis oil and vape brand acquired in 2020, Grassroots, a multi-state cannabis brand, and Curaleaf Hemp, which sells hemp-derived CBD products nationally. Through these labels Curaleaf spans flower, pre-rolls, vapes, concentrates, edibles and tinctures, and it also offers hemp-derived CBD topicals and tinctures. Curaleaf has grown largely through acquisitions of state-licensed operators and brands, assembling a footprint that reaches a large share of U.S. states where cannabis is legal for medical or adult use. It has also expanded into Europe, notably through its acquisition of EMMAC Life Sciences, giving it cultivation, processing and distribution assets in markets such as the United Kingdom, Germany, Italy, Spain and Portugal. The company positions itself as a leading global cannabis consumer packaged goods business, emphasizing scale, brand building and distribution. Curaleaf is led by executive chairman Boris Jordan, a long-time investor in the sector, and its management has focused on cost discipline, retail expansion and brand consolidation as U.S. cannabis markets matured. The company has been an active participant in industry advocacy for federal cannabis reform and banking access in the United States. Its shares trade in Canada and over the counter in the U.S. because major U.S. exchanges have historically declined to list plant-touching cannabis companies. Note: the supplied evidence snippet concerns Galloper Gold Corp., a mineral exploration company, and contains no information about Curaleaf; this dossier is therefore based on well-established public facts about Curaleaf Holdings rather than the supplied snippet.
History
Curaleaf was founded in 2017 as a vertically integrated cannabis company, taking its name from the combination of "cure" and "leaf." It grew rapidly by acquiring state-licensed medical cannabis operators and building out cultivation, processing and dispensary operations across the United States, at a time when a growing number of states were legalizing cannabis for medical and later adult use. A major turning point came in 2020 when Curaleaf acquired the Select brand from Cura Partners in an all-stock deal valued at roughly $830 million at announcement, adding one of the most recognized cannabis oil and vape brands in the United States to its portfolio. The same year it acquired Grassroots, a multi-state cannabis brand, from Green Goods/GR Companies, further expanding its wholesale brand reach. These deals transformed Curaleaf from a largely retail- and cultivation-driven operator into a brand-led consumer packaged goods business. Curaleaf also expanded internationally. Its acquisition of EMMAC Life Sciences, a European cannabis company, gave it cultivation, processing and distribution operations in the United Kingdom and continental Europe, including Germany, Italy, Spain and Portugal. The company has continued to build out its European medical cannabis footprint, positioning itself for growth as European countries liberalize medical cannabis access. In the United States, Curaleaf became one of the largest multi-state operators by revenue, with a national dispensary network and wholesale distribution to third-party retailers. It launched Curaleaf Hemp to sell hemp-derived CBD products, including tinctures and topicals, through mainstream retail channels and online, reaching consumers in states without medical or adult-use cannabis programs. Because U.S. national exchanges have historically declined to list plant-touching cannabis companies, Curaleaf's subordinate voting shares trade on the Canadian Securities Exchange under the ticker CURA, with a U.S. OTCQX quotation as CURLF. The company has been an active voice in industry advocacy for federal cannabis reform, including banking access legislation, and has pursued cost-reduction and restructuring programs as U.S. wholesale cannabis prices compressed in the early 2020s. Under executive chairman Boris Jordan, Curaleaf has emphasized brand consolidation, retail efficiency and international expansion as its core strategic priorities. Note: the supplied evidence snippet concerns Galloper Gold Corp. and does not mention Curaleaf; this history is drawn from well-established public facts about the company.
- 2020
Acquired the Select cannabis oil and vape brand from Cura Partners.
- 2020
Acquired the Grassroots multi-state cannabis brand.
- 2020
Acquired EMMAC Life Sciences, expanding into European cannabis markets.
- 2017
Curaleaf founded as a vertically integrated cannabis company.
Products and positioning
Vertically integrated, brand-led global cannabis consumer packaged goods company and one of the largest U.S. multi-state operators.
Select
Cannabis oil, vape and concentrate brand acquired in 2020.
Grassroots
Multi-state cannabis brand acquired in 2020.
Curaleaf Hemp
Hemp-derived CBD tinctures and topicals sold nationally.
Recent events
Reported
Curaleaf launches US$260 million takeover bid for Aurora Cannabis[2]
U.S.-based cannabis firm Curaleaf Holdings launched a takeover bid for Canadian producer Aurora Cannabis valuing it at about US$260 million, offering 0.3463 Curaleaf shares and 75 cents in cash per Aurora share, a total consideration of US$4 per share, open until December 1 subject to regulatory approvals and support from more than half of Aurora's independent shareholders.
Reported
Curaleaf completed acquisition of its remaining Florida asset stake[3]
Curaleaf issued shares and agreed to pay cash in exchange for the remaining 11.38% interest in Palliatech Florida LLC and a 7.97% interest in Curaleaf Florida, LLC, completing the acquisition of the final portion of its Florida operations.
Sources3 sources
Cite this profile: Cite the canonical profile. /brand-wiki/curaleaf-holdings · Editorial policy · How profiles are compiled